Gender vs. Fed/Fasted State vs. Capsule/Liquid Suspension Formulation Study .

Trial Profile

Gender vs. Fed/Fasted State vs. Capsule/Liquid Suspension Formulation Study .

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs SRT 2104 (Primary)
  • Indications Chronic obstructive pulmonary disease; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 05 Aug 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 21 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top